Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (Bulk RNA-Seq).

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (scRNA-Seq).

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment

Trem2 deficiency does not alter virus control but impairs phagocytic activity during neurotropic coronavirus induced demyelination

ATF3 is a converging node for AR signaling and fatty acid oxidation in castration-resistant prostate cancer

Pre- Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy

Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade

AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases

Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors

Opposing Roles for C/EBPα and Notch in Irradiation-induced Hematopoietic Stem Cell Defects

TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis

Molecular Signature of Pregnancy Associated Breast Cancer (PABC)

A receptor tyrosine kinase network comprised of FGFRs, EGFR, ERBB2, and MET drives growth and survival of HNSCC cell lines.

Gene expression of SLNs (Synthetic Lethal with Nutlin-3) on HCT116 cells